• Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 06 Nov 2024 05:07:16   America/New_York


    Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Akero Therapeutics, Inc. ( NASDAQ:AKRO - Get Free Report ) has ear
    Read more...
Share on,